文献速递白血病

儿童方案启发化疗降低成人急性淋巴细胞白血病中枢神经系统复发

Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2025-08-27

研究纳入1005例新诊断成人急性淋巴细胞白血病患者,596例接受Hyper-CVAD成人方案,409例接受PDT-ALL-2016儿童方案启发化疗。儿童方案组中枢神经系统复发5年累积发生率7.09%低于成人方案组11.24%(p=0.025),高危组中亦显著降低(6.75% vs 13.7%,p=0.003)。

要点

  • 儿童方案启发化疗组中枢神经系统复发5年累积发生率为7.09%,低于成人方案组的11.24%(p=0.025)。
  • 高危组中儿童方案组中枢神经系统复发5年累积发生率为6.75%,低于成人方案组的13.7%(p=0.003)。
  • 单因素分析显示儿童方案启发化疗是降低中枢神经系统复发的保护因素(OR=0.6,p=0.029)。

核心结论

  • 数据提示,与成人方案相比,儿童方案启发化疗可能降低成人急性淋巴细胞白血病的中枢神经系统复发风险。

研究设计与样本

  • 研究纳入1005例新诊断成人急性淋巴细胞白血病患者,其中596例接受Hyper-CVAD成人方案,409例接受PDT-ALL-2016儿童方案启发化疗。

主要发现

  • 成人方案组中枢神经系统复发比例为11.24%(67/596),儿童方案组为7.09%(29/409)。
  • 儿童方案组与成人方案组中枢神经系统复发5年累积发生率分别为7.09%与11.24%(p=0.025)。
  • 高危组中,儿童方案组中枢神经系统复发5年累积发生率为6.75%,低于成人方案组的13.7%(p=0.003)。
  • 单因素分析显示,儿童方案启发化疗是降低中枢神经系统复发的保护因素(OR=0.6,p=0.029)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Central nervous system (CNS) is the common site of extramedullary relapse in adult acute lymphoblastic leukaemia (ALL) and the outcome of CNS relapse patients remains poor. This study aimed to investigate whether a paediatric-inspired chemotherapy regimen can reduce CNS relapse in adult ALL compared to the adult regimen. A total of 1005 newly diagnosed adult patients with ALL were enrolled in this study, including 596 patients who received the Hyper-CVAD (cyclophosphamide, vincristine, doxorubicin[adriamycin], and dexamethason) adult regimen and 409 patients who treated with the Precision Classification-Directed Target Total Therapy-ALL-2016 (PDT-ALL-2016) paediatric-inspired chemotherapy regimen. 11.24% of patients treated with the adult regimen (67/596) experienced a CNS recurrence, whereas only 7.09% of patients (29/409) had CNS relapse under the paediatric-inspired chemotherapy regimen. The 5-year cumulative incidence of relapse in the CNS for the paediatric cohort and adult cohort was 7.09% and 11.24% respectively (p = 0.025). Even for patients in the high-risk group, the 5-year cumulative incidence of CNS relapse was significantly lower in the paediatric cohort compared with the adult cohort (6.75% vs. 13.7%, p = 0.003). The univariate analysis revealed that the paediatric-inspired regimen is a protective factor for reducing CNS relapse (OR = 0.6, p = 0.029). Collectively, our data suggest that paediatric-inspired chemotherapy may reduce the risk of CNS relapse in adult ALL compared to adult regimens.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Liang H, He B, Chen J, et al. Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia. Br J Haematol. 2025. PMID: 40859800. doi:10.1111/bjh.70067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。